Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Ann Card Anaesth ; 24(3): 281-287, 2021.
Article in English | MEDLINE | ID: mdl-34269255

ABSTRACT

Objective: In this study we compared noninvasive arterial pressure measurement using ClearSight™ vascular-unloading-technique (Edwards Lifesciences Corp, Irvine, CA) with invasive arterial pressure measurement during induction of anesthesia undergoing mayor cardiac surgery. Design: Prospective, monocentric. Setting: University hospital. Participants: 54 patients undergoing mayor cardiac surgery. Interventions: During induction all patients were simultaneously monitored with invasive (reference method) and noninvasive arterial pressure measurement (test-method) over a mean time period of 27 minutes. Measurements and Main Results: We observed slightly lower systolic and mean arterial pressures noninvasive than invasive. For systolic arterial pressure the mean of the differences was -18,05 mmHg (p < 0,05, SD ±16,78 mmHg), the mean arterial pressure MAP -5,47 mmHg (p < 0,05, SD ±11,08 mmHg) and for diastolic pressure -1,09 mmHg (p < 0,05, SD±11,15 mmHg),. The mean of the differences in heartrate was 1,15 (p < 0,05, SD±6,9 mmHg). When considering all measured values of the invasively measured MAP and the ClearSight ™ -MAP at the same timestamp over the recording interval, an almost identical progress can be seen that indicates a sufficient mapping of the hemodynamic changes. The percentage error for mean arterial, systolic and diastolic pressure measured by ClearSight™ amounts to 25,95 %, 26,77 % and 34,16 %, respectively. Conclusions: We conclude that ClearSight ™ is a good option for hemodynamic monitoring during induction of anesthesia. Taking into account the limitations, non-invasive arterial blood pressure measurement offers sufficient security to safely initiate anesthesia, especially when MAP is of particular interest. The use of non-invasive arterial blood pressure measurement with ClearSight ™ during induction of anesthesia in patients scheduled for major cardiac surgery is reliable and easy to use.


Subject(s)
Arterial Pressure , Cardiac Surgical Procedures , Anesthesia, General , Blood Pressure , Blood Pressure Determination , Humans , Prospective Studies
2.
Respiration ; 100(7): 600-610, 2021.
Article in English | MEDLINE | ID: mdl-33849036

ABSTRACT

BACKGROUND: Bronchoscopy is widely used and regarded as standard of care in most intensive care units (ICUs). Data concerning recommendations for on-call bronchoscopy are lacking. OBJECTIVES: Evaluation of recommendations, complications, and outcome of on-call bronchoscopies. METHOD: A retrospective single-centre analysis was conducted in a large university hospital. All on-call bronchoscopies performed outside normal working hours in the year before (period 1) and after (period 2) establishing a catalogue of recommendations for indications of on-call bronchoscopy on November 1, 2016, were included. RESULTS: Overall, 924 bronchoscopies in 538 patients were analysed. A relative reduction of 83.6% from 794 bronchoscopies in 432 patients (1.84 per patient) during period 1 to 130 in 107 patients (1.21 per patient) during period 2 was observed. Most bronchoscopies (812/924, 87.9%) were performed in ICUs, and 416 patients (77.3%) were intubated. Bronchoscopies for excessive secretions decreased significantly during period 2. Fifty-three of 130 bronchoscopies (40.8%) fulfilled the specified recommendations during period 2, in comparison with 16.8% in period 1 (p < 0.001). Complications were recorded in 58 of 924 procedures (6.3%) and were more frequent in period 2, especially moderate bleeding. In-hospital mortality of patients undergoing on-call bronchoscopy did not differ between periods and was 28.7 and 30.2% in periods 1 and 2, respectively. CONCLUSION: The introduction of recommendations for on-call bronchoscopy led to a significant decline of on-call bronchoscopies without negatively affecting outcome. More evidence is needed in on-call bronchoscopy, especially for ICU patients with intrinsic higher complication rates.


Subject(s)
Bronchoscopy/statistics & numerical data , Respiratory Tract Diseases/diagnosis , Adult , After-Hours Care , Aged , Bronchoscopy/adverse effects , Bronchoscopy/standards , Female , Germany , Hospitals, University , Humans , Intensive Care Units , Lung Diseases/diagnosis , Male , Middle Aged , Practice Guidelines as Topic , Retrospective Studies
3.
Eur Neuropsychopharmacol ; 44: 92-104, 2021 03.
Article in English | MEDLINE | ID: mdl-33487513

ABSTRACT

Ketamine and its (S)-enantiomer show distinct psychological effects that are investigated in psychiatric research. Its antidepressant activity may depend on the extent and quality of these psychological effects which may greatly differ between the enantiomers. Previous data indicate that the (S)-ketamine isomer is a more potent anesthetic than (R)-ketamine. In contrast, in subanesthetic doses (R)-ketamine seems to elicit fewer dissociative and psychotomimetic effects compared to (S)-ketamine. In this randomized double-blind placebo-controlled trial the effects of (R/S)-ketamine and (S)-ketamine on standardized neuropsychological and psychopathological measures were compared. After an initial bolus equipotent subanesthetic doses of (R/S)- and (S)-ketamine or placebo were given by continuous intravenous infusion to three groups of 10 healthy male volunteers each (n = 30). (R/S)-Ketamine and (S)-ketamine produced significant psychopathology and neurocognitive impairment compared to placebo. No significant differences were found between (R/S)-ketamine and (S)-ketamine. (S)-Ketamine administration did not result in reduced psychopathological symptomatology compared to (R/S)-ketamine as suggested by previous studies. However, this study revealed a somewhat more "negatively experienced" psychopathology with (S)-ketamine, which opens questions about potential "protective effects" associated with the (R)-enantiomer against some psychotomimetic effects induced by the (S)-enantiomer. As the antidepressant effect of ketamine might depend on a pleasant experience of altered consciousness and perceptions and avoidance of anxiety, the ideal ketamine composition to treat depression should include (R)-ketamine. Moreover, since preclinical data indicate that (R)-ketamine is a more potent and longer acting antidepressant compared to (S)-ketamine and (R/S)-ketamine, randomized controlled trials on (R)-ketamine and comparative studies with (S)-ketamine and (R/S)-ketamine are eagerly awaited.


Subject(s)
Analgesics/pharmacology , Ketamine , Antidepressive Agents/pharmacology , Consciousness , Healthy Volunteers , Humans , Ketamine/pharmacology , Male , Mental Disorders
4.
Article in German | MEDLINE | ID: mdl-32736387

ABSTRACT

According to the Transplantation Act (TPG), clinics and transplant commissaries (TxB) are obliged to ensure quality in donor evaluation. They are supervised. TxBs exist in every hospital that carries out organ harvesting and are always available. They are responsible for the conception of the organ donation process and should manage each individual case from the evaluation to the implementation of the patient's wishes.The evaluation for potential organ donors should be routine and supported by IT technology. The intensive care team must inform the TxB about living patients who "come into consideration" as organ donors. Reasons for exclusion can be known rejection, absolute medical contraindications and loss of function of all transplant organs. ICBF (irreversible cessation of brain function) deceased without reasons for exclusion must be reported to the DSO immediately. Talks with relatives about the neurological outcome, the ICBF diagnostics and organ donation are of fundamental importance for the implementation of the (presumed) wish of the potential organ donor and the relatives. The aim of the talks should be a sound decision with which the relatives can conclude. The TxBs support the ICU team to achieve this.Organ donation should be handled like an emergency. Typical bottlenecks are the instrument-based examinations and the availability of the operating room. The TxBs should draw up a schedule, communicate this to the interfaces and be available at all times during the entire organ donation process. Documentation of all details is important, as the TxBs must prepare detailed individual case analyses for quality assurance purposes and forward them to the clinic management and the DSO. Quality circles and especially peer review procedures are used and recommended as further QM tools.


Subject(s)
Organ Transplantation , Tissue and Organ Procurement , Critical Care , Hospitals , Humans , Tissue Donors
5.
BMC Neurol ; 14: 136, 2014 Jun 20.
Article in English | MEDLINE | ID: mdl-24950993

ABSTRACT

BACKGROUND: Pathogenic autoantibodies targeting the recently identified leucine rich glioma inactivated 1 protein and the subunit 1 of the N-methyl-D-aspartate receptor induce autoimmune encephalitis. A comparison of brain metabolic patterns in 18F-fluoro-2-deoxy-d-glucose positron emission tomography of anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis patients has not been performed yet and shall be helpful in differentiating these two most common forms of autoimmune encephalitis. METHODS: The brain 18F-fluoro-2-deoxy-d-glucose uptake from whole-body positron emission tomography of six anti-N-methyl-D-aspartate receptor encephalitis patients and four patients with anti-leucine rich glioma inactivated 1 protein encephalitis admitted to Hannover Medical School between 2008 and 2012 was retrospectively analyzed and compared to matched controls. RESULTS: Group analysis of anti-N-methyl-D-aspartate encephalitis patients demonstrated regionally limited hypermetabolism in frontotemporal areas contrasting an extensive hypometabolism in parietal lobes, whereas the anti-leucine rich glioma inactivated 1 protein syndrome was characterized by hypermetabolism in cerebellar, basal ganglia, occipital and precentral areas and minor frontomesial hypometabolism. CONCLUSIONS: This retrospective 18F-fluoro-2-deoxy-d-glucose positron emission tomography study provides novel evidence for distinct brain metabolic patterns in patients with anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis.


Subject(s)
Anti-N-Methyl-D-Aspartate Receptor Encephalitis/diagnostic imaging , Anti-N-Methyl-D-Aspartate Receptor Encephalitis/metabolism , Brain Chemistry/physiology , Encephalitis/diagnostic imaging , Encephalitis/metabolism , Glucose/metabolism , Proteins/immunology , Adult , Aged , Anti-N-Methyl-D-Aspartate Receptor Encephalitis/psychology , Autoantibodies/immunology , Encephalitis/immunology , Female , Fluorodeoxyglucose F18 , Humans , Intracellular Signaling Peptides and Proteins , Male , Middle Aged , Positron-Emission Tomography , Radiopharmaceuticals , Reproducibility of Results , Retrospective Studies
6.
Case Rep Neurol Med ; 2013: 843192, 2013.
Article in English | MEDLINE | ID: mdl-23533859

ABSTRACT

Anti-NMDA receptor (NMDAR) encephalitis is an autoimmune antibody-mediated neuropsychiatric disorder. The disorder is known to be associated with ovarian teratoma and predominantly affects young women. Here, we report the case of a 34-year-old woman with anti-NMDAR encephalitis, in which detailed investigations gave no specific hint for an ovarian teratoma. Despite this, and due to a continuous severe clinical syndrome, an ovarectomy was performed and histological examination revealed an occult teratoma. The ovarectomy led to a remarkable improvement even with a long term intensive care treatment for 11 months. The most important lesson to be learned from this instructive case is that even though none of the investigations was indicative for an ovarian teratoma, including an explorative laparoscopy with biopsy, there still may be an occult ovarian teratoma. This shows that tumour search and diagnosis are extremely important in patients presenting with anti-NMDAR encephalitis, and a laparotomy and ovarectomy is justified. Furthermore, removal of the teratoma even 11 months after a very severe course is still therapeutically effective.

7.
Anasthesiol Intensivmed Notfallmed Schmerzther ; 47(3): 188-96; quiz 197, 2012 Mar.
Article in German | MEDLINE | ID: mdl-22441690

ABSTRACT

The demand for donor organs continues to exceed the number of organs available for transplantation. The assistance to the family members of a potential donor in forefront of transplantation is as much important as to maintain donor organ function. Caring for a brain dead potential organ donor is therefore major challenge for nurses and physicians.The pathophysiological changes following brain death entail a high incidence of complications including hemodynamic instability, endocrine and metabolic disturbances, that jeopardize potentially transplantable organs. The knowledge of the complex physiologic changes is crucial to the development of effective donor management strategies.The management of potential organ donors is similar to the management of patients with severe sepsis. The main goal of that treatment is to achieve hemodynamic stability as well as the normalization of endocrine and metabolic disturbances. Donor optimization leads to increased organ procurement and contributes to improved organ function in the recipient.


Subject(s)
Brain Death , Organ Preservation/methods , Organ Transplantation/methods , Tissue Donors , Tissue and Organ Procurement , Humans
8.
Ann Thorac Surg ; 81(2): 519-21, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16427842

ABSTRACT

BACKGROUND: This study quantified the number of intraoperative microemboli in patients undergoing aortic arch surgery using selective cerebral perfusion (SCP) in comparison with those in patients undergoing ascending aortic replacement without circulatory arrest and SCP. METHODS: A transcranial Doppler monitoring of the medial cerebral artery was performed in 15 patients undergoing proximal arch replacement with SCP (SCP group) and 15 patients undergoing replacement of the ascending aorta (control group). RESULTS: There was no significant difference in the high-intensity transient signal counts between the SCP group and the control group at any phase. In the SCP group, 4.8% of microemboli occurred during cross-clamping, and only 0.6% occurred during SCP. In the control group, 4.6% occurred during cross-clamping. Most microemboli occurred after removing the cross-clamps in both groups; 92.2% in the SCP group and 92.1% in the control group. CONCLUSIONS: The present study demonstrated that outbreak frequency of microemboli during SCP was very low, and thus implies that the risk of embolic event that may be caused by SCP is very low.


Subject(s)
Aorta, Thoracic/surgery , Aortic Aneurysm/surgery , Brain/blood supply , Cardiac Surgical Procedures/adverse effects , Intracranial Embolism/etiology , Aged , Cerebral Arteries/diagnostic imaging , Female , Humans , Male , Middle Aged , Perfusion , Risk Assessment , Ultrasonography, Doppler, Transcranial
9.
Eur J Cardiothorac Surg ; 23(5): 776-81; discussion 781, 2003 May.
Article in English | MEDLINE | ID: mdl-12754032

ABSTRACT

OBJECTIVE: To minimize the side-effects of circulatory arrest times and profound hypothermia in patients undergoing pulmonary thromboendarterectomy (PTE) for chronic thromboembolic pulmonary hypertension (CTEPH). METHODS: Between March 2000 and June 2002, 30 patients (in New York Heart Association (NYHA) class III or IV) were operated for CTEPH using our modified technique. It includes moderate hypothermic (28-32 degrees C), total cardiopulmonary bypass (CPB) and simultaneous selective antegrade cerebral perfusion and occlusion of the bronchial arteries by introducing an occlusive balloon catheter into the descending aorta. The preoperative pulmonary vascular resistance in the cohort was 873+/-248dynes/s/cm(-5). RESULTS: Mean total CPB, cross-clamp times and duration of anterograde cerebral perfusion were 132+/-40, 98+/-21 and 21+/-10min, respectively. Mean core temperature 29.5+/-1.9 degrees C. The duration of postoperative mechanical ventilatory support was 34+/-44h and the mean stay in the ICU was 5+/-9 days. Seven patients had mild to moderate lung reperfusion injury, one transient neurological dysfunction. Three patients (10%) died during their hospital stay, two for multiorgan failure and one for persistent pulmonary hypertension. All patients had a significant pulmonary hemodynamic improvement and all achieved NYHA class I (P<0.01) status 4 weeks after discharge, remaining stable at a median follow-up time of 16 months (range, 1-29 months) postoperatively. CONCLUSIONS: These technical advances improve neurological outcome, control back-bleeding from bronchial arteries and avoid prolonged rewarming phases in patients undergoing PTE.


Subject(s)
Endarterectomy/methods , Hypertension, Pulmonary/surgery , Pulmonary Embolism/surgery , Chronic Disease , Cohort Studies , Critical Care/methods , Female , Humans , Length of Stay , Male , Middle Aged , Postoperative Care/methods , Preoperative Care/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...